{"id":510150,"title":"Qualifying notice for Zynlonta (284436) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T04:43:24.795000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-zynlonta-284436.html","snippet":"Qualifying notice for Zynlonta (284436) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e277127 Control number: 284436 Swedish Orphan Biovitrum AB (Publ) c/o [employee name removed]…","rawSnapshotUrl":"/api/snapshots/raw/510150","browseUrl":"https://replay.healtharchive.ca/job-6/20260216044324/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-zynlonta-284436.html#ha_snapshot=510150","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}